Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
Feb 17, 2026, 10:03 AM EST - Market open
Boundless Bio Employees
Boundless Bio had 64 employees as of December 31, 2024. The number of employees decreased by 8 or -11.11% compared to the previous year.
Employees
64
Change
-8
Growth
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$965,000
Market Cap
25.52M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Mar 31, 2024 | 72 | 0 | - |
| Dec 31, 2023 | 72 | - | - |
| Sep 30, 2023 | 71 | - | - |
| Jun 30, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Palatin Technologies | 29 |
| Daré Bioscience | 23 |
| Skye Bioscience | 16 |
| Rallybio | 15 |
| Exicure | 8 |
BOLD News
- 12 days ago - Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 4 weeks ago - Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 7 months ago - Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 9 months ago - Boundless Bio Announces Portfolio Prioritization and Runway Extension - GlobeNewsWire